These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 11201832

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Comparative efficacy of tiklid and aspirin in patients with unstable angina].
    Rebrov AP, Voskoboĭ IV.
    Ter Arkh; 2001; 73(12):25-9. PubMed ID: 11858103
    [Abstract] [Full Text] [Related]

  • 3. [Correlation between Willebrand's factor level and antithrombogenic activity of the vascular wall in patients with unstable angina pectoris].
    Voskoboĭ IV.
    Klin Med (Mosk); 2001; 79(11):19-21. PubMed ID: 11811101
    [Abstract] [Full Text] [Related]

  • 4. [The effect of fraxiparin on thrombocytic-vascular hemostasis in patients with unstable stenocardia].
    Timofeeva AV, Dobrotvorskaia TE, Dolgov VV, Arifullin ShS.
    Ter Arkh; 1993; 65(8):16-7. PubMed ID: 8211793
    [Abstract] [Full Text] [Related]

  • 5. [Functional status of thrombocytes and the anti-aggregative activity of the vascular wall in dyslipoproteinemias and ischemic heart disease].
    Mikhailova IA, Lipovetskiĭ BM, Magracheva EIa, Gurevich VS.
    Ter Arkh; 1989; 61(2):101-4. PubMed ID: 2727909
    [Abstract] [Full Text] [Related]

  • 6. [Clinical effectiveness and specific action of antiaggregants in patients with unstable angina].
    Rebrov AP, Voskoboĭ IV.
    Klin Med (Mosk); 2000; 78(7):32-6. PubMed ID: 10979639
    [Abstract] [Full Text] [Related]

  • 7. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
    Jäger E, Sinzinger H, Widhalm K, Kaliman J, Höfer R.
    Wien Klin Wochenschr; 1982 Sep 03; 94(16):421-5. PubMed ID: 7147981
    [Abstract] [Full Text] [Related]

  • 8. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C, Ritter MM, Richter WO, Minkenberg R, Schwandt P.
    Metabolism; 2001 Feb 03; 50(2):166-70. PubMed ID: 11229424
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Influence of type IIa, IIb and IV-hyperlipoproteinemia on platelet prostaglandin sensitivity, plasma thromboxane B2 and platelet half-life.
    Strobl-Jäger E, Widhalm K, Sinzinger H.
    Prostaglandins Leukot Med; 1986 Nov 03; 25(1):39-47. PubMed ID: 3540998
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The combination of psoriasis with different types of lipoproteinemias. 2. The characteristics of the dyslipoproteinemias caused by disorders in triacylglyceride transport in psoriasis].
    Keshileva ZB, Kosukhin AB, Polevaia LG.
    Vestn Dermatol Venerol; 1990 Nov 03; (5):7-11. PubMed ID: 2402946
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased in vitro platelet aggregation in hypertriglyceridemias.
    Riess H, Merk W, Falkner C, Hiller E.
    Thromb Res; 1986 Feb 01; 41(3):281-9. PubMed ID: 3705010
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pirifibrate in the treatment of hyperlipoproteinemias: a multicenter study.
    Domingo AJ, Gutiérrez JA, Menéndez JA, Micó L, Muñoz M, de Oya M.
    Clin Ther; 1980 Feb 01; 3(3):219-26. PubMed ID: 7459931
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.